journal article·2022-07Open access

Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

Vanesa Porto, David Buceta, Blanca Domínguez, Carmen Carneiro, Erea Borrajo, María Fraile, Nerea Davila‐Ferreira, Iria R. Arias, José M. Blanco, Maria C. Blanco, Juan M. Devida, Lisandro J. Giovanetti, Félix G. Requejo, Juan C. Hernández‐Garrido, José J. Calvino, Miguel López‐Haro, Giampaolo Barone, Andrew M. James, Tomás García‐Caballero, Diego M. González‐Castaño, Martin Treder, Wolfgang Huber, Anxo Vidal, Michael P. Murphy, M. Arturo López‐Quintela, Fernando Domínguez

Advanced Functional Materials· Volume 32· Issue 29

Abstract

Abstract Low atomicity clusters present properties dependent on the size, due to the quantum confinement, with well‐defined electronic structures and high stability. Here it is shown that Ag5 clusters catalyze the complete oxidation of sulfur to S+6. Ag5 catalytic activity increases with different oxidant species in the order O2 ≪ H2O2 < OH•. Selective oxidation of thiols on the cysteine residues of glutathione and thioredoxin is the primary mechanism human cells have to maintain redox homeostasis. Contingent upon oxidant concentration, Ag5 catalyzes the irreversible oxidation of glutathione and thioredoxin, triggering apoptosis. Modification of the intracellular environment to a more oxidized state to mimic conditions within cancer cells through the expression of an activated oncogene (HRASG12V) or through ARID1A mutation, sensitizes cells to Ag5 mediated apoptosis. While cancers evolve to evade treatments designed to target pathways or genetic mutations that drive them, they cannot evade a treatment that takes advantage of aberrant redox homeostasis, which is essential for tumor progression and metastasis. Ag5 has antitumor activity in mice with orthotopic lung tumors reducing primary tumor size, and the burden of affected lymphatic nodes. The findings suggest the unique intracellular redox chemistry of Ag5 may lead to new redox‐based approaches to cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology and Centro de Investigaciones en Medicina Molecular y Enfermedades Crónicas (CIMUS) IDIS Universidade de Santiago de Compostela Santiago de Compostela 15782 Spain

Departments of Physical Chemistry and Applied Physics Nanomag Laboratory IIT Universidade de Santiago de Compostela Santiago de Compostela 15782 Spain

Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA) (FCE, UNLP and CONICET) La Plata 1900 Argentina

Department of Material Science and Metallurgic Engineering and Inorganic Chemistry Faculty of Science University of Cadiz Puerto Real (Cádiz) Cádiz 11510 Spain

Department of Biological, Chemical and Pharmaceutical Sciences and Technologies University of Palermo Palermo 90128 Italy

MRC Mitochondrial Biology Unit University of Cambridge Cambridge CB2 0XY UK

Department of Morphological Sciences School of Medicine‐University Clinical Hospital Universidade de Santiago de Compostela Santiago de Compostela 15782 Spain

Radiation Physics Laboratory RIAIDT Universidade de Santiago de Compostela Santiago de Compostela 15782 Spain

Arjuna Therapeutics Milladoiro 15895 Spain

European Molecular Biology Laboratory (EMBL) 69115 Heidelberg Germany

Funding

Laboratório Nacional de Luz Síncrotron · Xunta de Galicia

References (72)

Show source-provided references
1. 10.1016/j.cell.2015.07.01710.1016/j.cell.2015.07.017 ↗
2. 10.1016/j.cell.2015.07.01610.1016/j.cell.2015.07.016 ↗
3. 10.1016/j.cmet.2018.10.01410.1016/j.cmet.2018.10.014 ↗
4. 10.1038/s41586-020-2475-610.1038/s41586-020-2475-6 ↗
5. 10.1042/BJ2008138610.1042/BJ20081386 ↗
6. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
7. 10.1089/ars.2017.742510.1089/ars.2017.7425 ↗
8. 10.1016/j.chembiol.2018.12.00210.1016/j.chembiol.2018.12.002 ↗
9. 10.1016/j.ccell.2014.11.01910.1016/j.ccell.2014.11.019 ↗
10. 10.1038/nchem.172110.1038/nchem.1721 ↗
11. 10.1021/acs.chemrev.7b0052410.1021/acs.chemrev.7b00524 ↗
12. 10.1021/acs.chemrev.6b0076910.1021/acs.chemrev.6b00769 ↗
13. 10.1021/acs.chemrev.5b0070310.1021/acs.chemrev.5b00703 ↗
14. 10.1002/adma.20180131710.1002/adma.201801317 ↗
15. 10.1002/anie.20150291710.1002/anie.201502917 ↗
16. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
17. 10.1038/nrd.2018.17410.1038/nrd.2018.174 ↗
18. 10.1038/nrm225610.1038/nrm2256 ↗
19. 10.1016/j.freeradbiomed.2008.05.00410.1016/j.freeradbiomed.2008.05.004 ↗
20. 10.1016/j.bbagen.2012.09.01810.1016/j.bbagen.2012.09.018 ↗
21. 10.1038/nmeth.121210.1038/nmeth.1212 ↗
22. 10.1016/j.str.2004.01.00910.1016/j.str.2004.01.009 ↗
23. 10.14348/molcells.2016.236810.14348/molcells.2016.2368 ↗
24. 10.14348/molcells.2016.234910.14348/molcells.2016.2349 ↗
25. 10.1100/tsw.2010.10410.1100/tsw.2010.104 ↗
26. 10.1016/S0021-9258(18)33504-X10.1016/S0021-9258(18)33504-X ↗
27. 10.7554/eLife.0252310.7554/eLife.02523 ↗
28. 10.1016/j.ccell.2018.12.00910.1016/j.ccell.2018.12.009 ↗
29. 10.14348/molcells.2016.235110.14348/molcells.2016.2351 ↗
30. 10.1016/j.bcp.2008.08.02110.1016/j.bcp.2008.08.021 ↗
31. 10.3390/ijms1210716310.3390/ijms12107163 ↗
32. 10.1038/nrd400210.1038/nrd4002 ↗
33. 10.1146/annurev-cancerbio-041916-06580810.1146/annurev-cancerbio-041916-065808 ↗
34. 10.1016/j.freeradbiomed.2018.05.08110.1016/j.freeradbiomed.2018.05.081 ↗
35. 10.4103/0973-1482.5513310.4103/0973-1482.55133 ↗
36. 10.1111/febs.1510110.1111/febs.15101 ↗
37. 10.1016/j.ccell.2018.03.02210.1016/j.ccell.2018.03.022 ↗
38. 10.1016/S0006-2952(99)00301-910.1016/S0006-2952(99)00301-9 ↗
39. 10.2183/pjab.88.43410.2183/pjab.88.434 ↗
40. 10.1038/onc.2008.30110.1038/onc.2008.301 ↗
41. 10.1126/science.275.5306.164910.1126/science.275.5306.1649 ↗
42. 10.1016/j.chembiol.2017.08.02810.1016/j.chembiol.2017.08.028 ↗
43. 10.1073/pnas.100342810710.1073/pnas.1003428107 ↗
44. 10.1016/j.cell.2015.12.03410.1016/j.cell.2015.12.034 ↗
45. 10.1016/j.cmet.2019.08.01310.1016/j.cmet.2019.08.013 ↗
46. 10.1038/nprot.2008.22610.1038/nprot.2008.226 ↗
47. 10.1038/srep1910310.1038/srep19103 ↗
48. 10.1038/nrc189310.1038/nrc1893 ↗
49. 10.1016/j.jconrel.2016.07.04810.1016/j.jconrel.2016.07.048 ↗
50. 10.1038/nrclinonc.2016.6010.1038/nrclinonc.2016.60 ↗
51. 10.1038/ncomms620310.1038/ncomms6203 ↗
52. Minassian L. M. · 2019 · 123
53. 10.1107/S090904959900812210.1107/S0909049599008122 ↗
54. 10.1016/S1386-1425(98)00153-X10.1016/S1386-1425(98)00153-X ↗
55. 10.1063/1.46491310.1063/1.464913 ↗
56. 10.1103/PhysRevB.37.78510.1103/PhysRevB.37.785 ↗
57. 10.1007/BF0053348510.1007/BF00533485 ↗
58. 10.1063/1.44426710.1063/1.444267 ↗
59. 10.1063/1.44879910.1063/1.448799 ↗
60. 10.1021/cr500441910.1021/cr5004419 ↗
61. 10.1021/ja00051a04010.1021/ja00051a040 ↗
62. 10.1002/jcc.1018910.1002/jcc.10189 ↗
63. 10.1002/ijch.19930005110.1002/ijch.199300051 ↗
64. Frisch J. · 2009
65. 10.1016/0076-6879(67)10016-510.1016/0076-6879(67)10016-5 ↗
66. 10.1016/0076-6879(95)60127-910.1016/0076-6879(95)60127-9 ↗
67. 10.1016/j.ab.2013.08.01310.1016/j.ab.2013.08.013 ↗
68. 10.1073/pnas.12206139910.1073/pnas.122061399 ↗
69. 10.1371/journal.pone.014602110.1371/journal.pone.0146021 ↗
70. 10.1038/s41586-019-1186-310.1038/s41586-019-1186-3 ↗
71. 10.1093/nar/30.9.e3610.1093/nar/30.9.e36 ↗
72. 10.1007/978-1-59745-443-8_810.1007/978-1-59745-443-8_8 ↗